Sorin B, Pineton de Chambrun M, Haroche J, Freund Y, Miyara M, Charlotte F, Lebrun-Vignes B, Amoura Z, Cohen Aubart F
Service de médecine interne, institut E3M, centre national de référence maladies auto-immunes systémiques rares, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
Service de médecine interne, institut E3M, centre national de référence maladies auto-immunes systémiques rares, hôpital Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France; UPMC, université Paris VI, sorbonnes université, 75013 Paris, France.
Rev Med Interne. 2016 Feb;37(2):131-4. doi: 10.1016/j.revmed.2015.07.003. Epub 2015 Sep 26.
Nitrofurantoin is a commonly used drug which can have liver and pulmonary adverse effects. Among hepatic nitrofurantoin-induced adverse effects, autoimmune hepatitis is a rare complication which must not be mistaken as a toxic hepatitis.
We report an 86-year-old woman who presented with acute hepatitis after a 3-month course of nitrofurantoin administration for urinary tract infections. She reported a previous hepatitis after treatment by nitrofurantoin twenty years before. Biological analysis showed polyclonal hypergammaglobulinemia, positive test for antinuclear antibodies and smooth muscle antibodies. Finally, liver histology showed lymphocytic infiltration, marked necrotic and inflammatory activity consistent with the diagnosis of autoimmune hepatitis. Nitrofurantoin was discontinued. Outcome of autoimmune hepatitis was good with corticosteroids and azathioprine but two months later, the patient died from a refractory global heart failure.
Nitrofurantoin-induced autoimmune hepatitis is a severe condition which must be systematically discussed in patients taking nitrofurantoin who present with acute hepatitis. Hypergammaglobulinemia is an easily obtained blood marker, which can suggest this diagnosis. Treatment relies on nitrofurantoin eviction, corticosteroids and sometimes azathioprine. Outcome is usually favorable.
呋喃妥因是一种常用药物,可产生肝脏和肺部不良反应。在呋喃妥因引起的肝脏不良反应中,自身免疫性肝炎是一种罕见的并发症,切不可误诊为中毒性肝炎。
我们报告一名86岁女性,在接受为期3个月的呋喃妥因治疗尿路感染后出现急性肝炎。她报告称20年前曾在呋喃妥因治疗后出现过肝炎。生物学分析显示多克隆高球蛋白血症、抗核抗体和平滑肌抗体检测呈阳性。最后,肝脏组织学检查显示淋巴细胞浸润,坏死和炎症活动明显,符合自身免疫性肝炎的诊断。停用了呋喃妥因。自身免疫性肝炎经皮质类固醇和硫唑嘌呤治疗后效果良好,但两个月后,患者死于难治性全心衰竭。
呋喃妥因诱导的自身免疫性肝炎是一种严重疾病,对于服用呋喃妥因后出现急性肝炎的患者必须进行系统讨论。高球蛋白血症是一种易于获得的血液标志物,可提示该诊断。治疗依赖于停用呋喃妥因、使用皮质类固醇,有时还需使用硫唑嘌呤。预后通常良好。